Skip to main content
Log in

HLA-Associations in Leponex®/Clozaril® (Clozapine)-Induced Granulocytopenia and Agranulocytosis

Statistical Viewpoints

  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

This paper describes a statistical analysis of the simultaneous occurrence of 48 human leucocyte antigens (HLAs) in an attempt to predict whether a patient treated with clozapine will develop granulocytopenia or agranulocytosis. Whereas the numerical results show that use of HLAs does not appear to satisfy the intended purpose, emphasis is placed on the statistical methodology recommended for a problem of this type. Other work in this area is critically discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abt K. On the identification of the significant independent variables in linear models. Metrika 12: 1–15, 81-96, 1967

    Article  Google Scholar 

  • Abt K. Planning controlled clinical trials on the basis of Descriptive Data Analysis. Statistics in Medicine 10: 777–795, 1991

    Article  PubMed  CAS  Google Scholar 

  • Armitage P, Berry G. Statistical methods in medical research. 2nd ed., Blackwell Scientific Publications, Oxford, 1987

    Google Scholar 

  • Hald A. Statistical tables and formulas. John Wiley Inc., New York, 1952

    Google Scholar 

  • Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Archives of General Psychiatry 47: 945–948, 1990

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abt, K., Gülich, A., Krupp, P. et al. HLA-Associations in Leponex®/Clozaril® (Clozapine)-Induced Granulocytopenia and Agranulocytosis. Drug-Safety 7 (Suppl 1), 10–16 (1992). https://doi.org/10.2165/00002018-199200071-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199200071-00006

Keywords

Navigation